Global Drug Intermediates and APIs Market Procurement Intelligence Report 2019 - ResearchAndMarkets.com

The "Global Drug Intermediates and APIs Market - Procurement Intelligence Report" report has been added to ResearchAndMarkets.com's offering.

One of the procurement best practices for buyers is to adopt big data analytics in the procurement process to gain benefits such as demand projection, insights into pricing trends of APIs and intermediates from historical data, among others.

According to the report, one of the key growth contributors for the global drug intermediates and APIs market is the increasing demand from the pharmaceutical companies that are one of the key end-users.

Further, the report states that one of the key category management strategies for the buyers in the global drug intermediates and APIs market is to engage with suppliers who can ensure supply assurance.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains actionable insights to improve source-to-contract cycle performance in addition to a PESTLE analysis.

Key Topics Covered:

PART 01: EXECUTIVE SUMMARY

PART 02: MARKET INSIGHTS

• Global category spend
• Category spend growth
• Spend segmentation by region
• Regional spend dynamics
• Regional influence on global spend
• Regional spend opportunity for suppliers

PART 03: CATEGORY PRICING INSIGHTS

• Pricing outlook
• Supplier cost structure
• Outlook for input costs
• Total cost of ownership analysis
• Overview of pricing models
• Comparison of pricing models
• Supply chain margins
• Cost drivers: Impact on pricing
• Volume drivers: Impact on pricing

PART 04: COST-SAVING OPPORTUNITIES

• Supplier-side levers
• Buyer-side levers
• Quantifying cost-saving opportunities
• Quantifying cost savings by negotiation strategies

PART 05: BEST PRACTICES

• Innovation and success stories
• Procurement excellence best practices
• Procurement best practices
• Sustainability practices
• Sustainability best practices

PART 06: CATEGORY ECOSYSTEM

• Market favorability index for suppliers
• Competitiveness index for suppliers
• Buyer power
• Supplier power
• Threat of new entrants
• Threat of substitutes
• Buyer ecosystem
• Supplier ecosystem

PART 07: CATEGORY MANAGEMENT STRATEGY

• Category management objectives
• Supplier and buyer KPIs
• Outsourcing category management activities
• Risk management

PART 08: CATEGORY MANAGEMENT ENABLERS

• Procurement organization
• Category enablers

PART 09: SUPPLIERS SELECTION

• RFx essentials
• Supplier selection criteria
• Service level agreement
• Incumbent supplier evaluation metrics

PART 10: SUPPLIERS UNDER COVERAGE

• Overview
• Supplier positioning
• Profile: Pfizer Inc.
• Profile: Merck & Co. Inc.
• Profile: Sanofi
• Profile: Boehringer Ingelheim International GmbH
• Profile: Novartis AG
• Profile: Evonik Industries AG

PART 11: US MARKET INSIGHTS

• Category spend in the US
• Pricing outlook
• Supplier cost structure in the US
• Margins of suppliers in the US
• Category cost drivers
• Category volume drivers
• Overview of best practices in the US
• Procurement best practices in the US
• US supply market overview
• Supplier positioning for the US
• Regional category risks

PART 12: CATEGORY DEFINITION

• Category hierarchy
• Category scope
• Category map

PART 13: APPENDIX

For more information about this report visit https://www.researchandmarkets.com/r/juh43e

View source version on businesswire.com: https://www.businesswire.com/news/home/20191210005570/en/